v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (24,046) $ (49,510) $ (46,496)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization 11,295 19,436 16,607
Estimated credit losses (recoveries) 437 (58) 955
Share-based compensation 1,513 2,421 3,171
Impairment loss on held for sale property and equipment 130 0 0
Impairment loss related to goodwill and intangible assets 0 6,655 15,526
Impairment loss on operating lease right-of-use assets 0 220 133
Loss on asset disposition 773 685 218
Change in value of marketable securities (796) (1,326) (1,438)
Changes in operating assets and liabilities (net of the effect of acquisitions):      
Accounts and notes receivable (3,195) 835 (300)
Inventory 1,794 24,557 13,773
Prepaid expenses and other assets 91 477 3,898
Accounts payable and accrued liabilities 1,511 (3,712) (3,035)
Operating leases (151) (173) 46
Customer deposits 1,595 (2,955) 1,021
Payroll and payroll tax liabilities (66) 486 (2,502)
Sales taxes payable (441) 128 (156)
Other 109 35 0
Net cash and cash equivalents (used in) provided by operating activities (9,447) (1,799) 1,421
Cash flows from investing activities:      
Acquisitions, net of cash acquired (1,013) 0 (3,050)
Purchase of property and equipment (536) (1,978) (6,698)
Purchase of marketable securities (35,665) (52,639) (98,680)
Maturities of marketable securities 49,787 60,193 96,758
Proceeds from disposals of assets 29 150 265
Net cash and cash equivalents provided by (used in) investing activities 12,602 5,726 (11,405)
Cash flows from financing activities:      
Principal payments on long-term debt 0 0 (50)
Common stock withheld for employee payroll taxes (220) (176) (263)
Common stock repurchased 0 (6,037) 0
Net cash and cash equivalents used in financing activities (220) (6,213) (313)
Net increase (decrease) in cash and cash equivalents 2,935 (2,286) (10,297)
Cash and cash equivalents at beginning of year 27,471 29,757 40,054
Cash and cash equivalents at end of year 30,406 27,471 29,757
Supplemental Information:      
Right-of-use assets obtained in exchange for new or modified operating lease liabilities 1,049 3,506 4,289
Fair value of common stock issued in business combination 159 0 0
Fair value of contingent consideration 83 0 0
Cash paid for interest 0 70 98
Non-cash repurchase of liability awards 0 0 653
Non-cash issuance of a note receivable 0 0 299
Liability redemption associated with business acquisition $ 0 $ 0 $ 120

Source

HTML PDF
ZIP